Macrocytic anemia screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
(One intermediate revision by one other user not shown) | |||
Line 2: | Line 2: | ||
{{Macrocytic anemia}} | {{Macrocytic anemia}} | ||
{{CMG}}; {{AE}} {{ADS}} | |||
==Overview== | |||
There is insufficient evidence to recommend routine screening for [[megaloblastic anemia]] | |||
==Screening== | |||
There is insufficient evidence to recommend routine screening for [[megaloblastic anemia]] | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Line 11: | Line 16: | ||
[[Category:Blood disorders]] | [[Category:Blood disorders]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
Latest revision as of 19:30, 6 November 2018
Macrocytic anemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Macrocytic anemia screening On the Web |
American Roentgen Ray Society Images of Macrocytic anemia screening |
Risk calculators and risk factors for Macrocytic anemia screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]
Overview
There is insufficient evidence to recommend routine screening for megaloblastic anemia
Screening
There is insufficient evidence to recommend routine screening for megaloblastic anemia